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Abstract 
With the rapid development of powerful protein evolution and enzyme-screening technologies, there 
is a growing belief that optimum conditions for biotransformation processes can be established 
without the constraints of the properties of the biocatalyst. These technologies can then be applied to 
find the 'ideal biocatalyst' for the process. In identifying the ideal biocatalyst, the processes of gene 
discovery and enzyme evolution play major roles. However, in order to expand the pool genes for in 
vitro evolution, new technologies, which circumvent the limitations of microbial culturability, must be 
applied. These technologies, which currently include metagenomic library screening, gene-specific 
amplification methods and even full metagenomic sequencing, provide access to a volume of 
'sequence space' that is not addressed by traditional screening. 
The ideal biocatalyst 
The concept of the 'ideal biocatalyst' has grown out of a perceived shift in the paradigm for the 
selection of biocata-lysts for industrial application [1]. The traditional approach to the 
implementation of a functional enzyme within the context of an industrial or commercial biocatalytic 
process has been the selection of an enzyme whose properties were less than ideal for the optimum 
process. Selection was typically via de novo screening or from the existing catalogue of commercially 
available enzymes. The catalyst would then be further modified using any of a battery of genetic and 
molecular tools in order to adapt the catalyst to better suit the process requirements. The new 
paradigm, which suggests that the process could be designed optimally without being constrained by 
consideration of the properties of the biocatalyst, has evolved from the recent development of new 
and powerful methods for enzyme redesign and enzyme discovery. The methods allow us to move 
more effectively through, and to probe more comprehensively, the variations in protein sequence that 
dictate enzyme functional properties. 
 
Sequence space 
Every undergraduate student in biochemistry learns that the hypothetical range of proteins which can 
be built from the 20 natural amino acids is staggeringly large; 20100 for a protein of only 100 amino 
acids in length. This concept has come to be known as 'sequence space' [2], a multidimensional 
volume representing all possible polypeptide combinations for a given sequence length. The 
occupancy of 'sequence space' is dictated by many factors. Most important are thermodynamic 
requirements for building stable and functional protein structures. 
 
The protein sequences currently known to science from protein sequencing, from the translation of 
directly cloned genes and from sequenced genomes, total between 104 and 105. Clearly, these few 
 
 
Page | 2  
 
sequences occupy a relatively small proportion of the sequence space offered by a fully random 
selection of amino acids (10201 for 200-amino-acid proteins). There are a number of possible reasons 
why such a small proportion of total sequence space is occupied (Table 1). It is immediately and 
instinctively obvious that certain regions of protein sequence space are unlikely to be occupied (e.g. a 
protein of the sequence His200 is unlikely to be found in natural biological systems). Conversely, 
accumulated protein sequence data indicate that some regions are heavily occupied (e.g. highly 
conserved proteins such as members of the chaperone family will occupy quite localized regions of 
sequence space). To the authors' knowledge, no attempts have been made to develop tools for 
analysing and/or representing the occupied and unoccupied regions of sequence space. Such analyses 
may be particularly instructive in further developing an understanding of the thermodynamic basis of 
protein structure and function. 
 
Moving around in sequence space 
Our understanding of the occupancy of protein sequence space is derived from the sequences 
available in protein (and nucleic acid) databases. These sequences are, in turn, dependent on the range 
of known and available genomes. Developments in protein engineering and evolution have provided 
methods for moving short distances in sequence space. The 'classical' techniques of random and site-
specific mutagenesis, which are used to replace a single or limited number of amino acids, only 
provide access to near neighbours (Figure 1). More recently developed methods, including error-
prone PCR [3], saturation mutagenesis [4], domain shuffling [5] etc., give access to more distant 
neighbours (Figure 1). With the exception of saturation mutagenesis, the scope of these techniques is 
nevertheless limited by the range of genes and genomes that can be used as templates or sources of 
sequence data. 
 
Table 1   Factors dictating occupancy of sequence space 
Possible cause  Basis for occupancy/absence 
Thermodynamic limitations       Some amino acid sequences could never fulfil the thermodynamic requirements of a functional pprotein 
Functional limitations                The functional requirements of certain protein types (e.g. membrane-spanning proteins) reduce the     
                               range of amino acids that can be selected 
Evolutionary limitations Evolution from a relatively small population of progenitor sequences may not have had time 
to fully explore sequence-space options 
Evolutionary pressure The requirements of biological systems may be well satisfied with existing sequences, 
reducing the evolutionary pressure to explore new areas of sequence space 
Database inadequacy The occupancy of protein sequence space is much wider than currently perceived due to the 
limited protein sequence information available 
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The extent of this limitation has only become evident in the past decade with the development of 
small subunit rRNA gene analysis as a tool for the study of molecular ecology, particularly of 
prokaryotic populations [6]. Molecular phylo-genetic analysis of microbial diversity has clearly 
demonstrated that a very high proportion of microbial 'species' have never been cultured. Such 
studies have led to the development of the concept of 'unculturables' [7], currently thought to 
represent between 90 and 99.9% of extant microbial species, depending on the biotope. Current 
estimates of prokaryotic and lower eukaryotic diversity may be in excess of 107 distinct species [8,9]. 
Extremophilic, particularly thermo-philic, biotopes may have a higher proportionofunculturable 
microbial species than many less 'extreme' biotopes. 
  
The presence of such substantial proportions of 'uncultur-able' species in any environmental sample 
highlights the limitations of any gene discovery protocol that is dependent on culturing, no matter 
how sophisticated the amplification or selection process. While there is clearly an on-going need for 
new and innovative culturing technologies, there is also a requirement for alternative gene-/genome-
discovery strategies that are culture-independent. These novel methods are now incorporated in the 
newly evolved field of 'metagenomics'; the culture-independent assessment of microbial ecology. 
 
Metagenomic gene discovery as an option for wider access to sequence space 
The application of metagenomics to (culture-independent) gene discovery was initiated with the 
simultaneous development in several laboratories of direct cloning and expression of multigenomic 
DNA extracts [8,10-16]. Depending on the choice of vector and host, either single genes and 
pri¬mary gene products, or secondary metabolites from the expression of complete operons, could 
be targeted (Table 2). 
 
Figure 1   Options for moving around in sequence 
space 
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With the 'maturation' of this technology, efforts have been made to circumvent some of the 
limitations inherent in the preparation and screening of metagenomic libraries. Meta-genomic PCR 
amplification methods, which have been used successfully to identify families of homologous genes 
([18] and R.A. Cameron and D.A. Cowan, unpublished work), suffer from the limitation that the 
primary PCR generates only partial gene sequences. Full-length sequences are subsequently obtained 
by hybridization screening of a complete metagenomics library or by genome walking [19]. 
 
It is generally assumed that PCR-based technologies, where known sequences are required for primer 
design, probe near-neighbour regions of sequence space (Figure 1). Inter¬estingly, our early results 
do not support this view. In amplifying metagenomic DNA extracts using primer sets specific to 
bacterial lipase and nitrile hydratase a-subunit sequences, we cloned and sequenced sets of putative 
gene fragments (Figure 2). While the nitrile hydratase genes show very high homology to each other 
and known full-length genes (i.e. we did not move far in sequence space), the putative lipase gene 
amplicons showed very low levels of homology, suggesting that we were probing a much larger 
volume of sequence space. 
 
Table 2  Vector/host combinations for metagenomic gene targeting 
NA, not applicable; BAC, bacterial artificial chromosome. 
 
 
Vector Host Average insert size (kb) Target gene/product Reference 
Lambda phage Escherichia coli 1.8-4.2 Chitinase [13] 
NA Streptomyces lividans NA Terragine antibiotics [14] 
BAC Escherichia coli 10-20 and 40-50 DNase, lipase, amylase [12] 
BAC Escherichia coli 10-20 and 40-50 N-Acyk-tyrosine antibiotics [15] 
Cosmid/lambda phage Escherichia coli >30 Biotin biosynthesis partway [17] 
pBluescript plasmid Escherichia coli 5-8 Lipase [10] 
pCR-TOPO© plasmid Escherichia coli 10-18 Tetrapyrrole biosynthesis genes [16] 
 
 
A number of PCR-based approaches designed to recover the flanking regions of a DNA fragment once its 
sequence is known have been reported (see review in [20]). Although suitable for use at a single-genome 
level these methods are technically more difficult to apply at the metagenomic level due to the increased 
complexity of a multigenomic DNA sample. A desire to simplify this process led us to look at the 
development of other novel approaches. 
 
One potentially powerful approach is based on in vitro hybridization of a genomic DNA sample with the 
target gene fragment acting as a probe (Figure 3). Genomic DNA is fragmented and priming sites are 
introduced by ligation of adapters. The gene-specific PCR product is then used as a driver to selectively 
hybridize to full-length gene fragments in the DNA sample. These partially double-stranded full-length gene 
fragments can then be selectively separated from the single-stranded background (genomic DNA). To 
remove any residual background the adapters are removed; because the full-length gene fragments are only 
partially double stranded the priming sites will remain intact as the restriction enzyme can only act on 
double-stranded DNA within the priming site. The full-length gene can then be amplified. This method is 
particularly powerful for multigenomic cloning as the use of degenerate gene-specific primers on a 
metagenomic sample typically yields a population of target gene fragments (R.A. Cameron, J.J. Smith and 
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D.A. Cowan, unpublished work). Each member of the pool of target fragments can be used to probe the 
metagenomic sample, potentially yielding a number of novel full-length genes simultaneously. 
 
 
 
 
 
Figure 2  Neighbourhood joining tree representations of partial gene sequences derived from PCR a 
amplification of metagenomic extracts 
(a) Putative lipase sequences derived from Antarctic Dry Valley soil DNA extracts. (b) Putative nitrile hydratase 
 a-subunit sequences derived from geothermal sediment DNA extracts. 
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.Sequencing the metagenome 
With the rapidly increasing capacity for high-throughput screening, and the associated reduction in 
sequencing costs, the possibility exists of circumventing all current approaches to metagenomic gene 
discovery by merely sequencing the entire prokaryotic metagenome. While this is no trivial task, it is 
worth considering the scale and the likely cost effectiveness of the process. 
 
An 'average' environmental sample will contain hundreds or even thousands of different prokaryotic 
and eukaryotic species [21-23]. A temperate eutrophic soil DNA extract (containing, conservatively, 
500 bacterial 5 Mbp genomes and 100 fungal 20 Mbp genomes) will therefore constitute around 5 
Gbp of DNA sequence (rather larger than a human genome). While the sequencing cost would be 
projected at a few hundreds of millions of dollars (for comparison, the U.S. Human Genome Project 
budget was predicted to exceed $US450 million), such a metagenome sequencing project would be 
expected to yield 2-3 million open reading frames, at a projected cost of around $200 per identified 
open reading frame. While the cost per open reading frame is surprisingly low, this is clearly not an 
efficient method for mining specific genes. For gene types which occur in limited numbers in each 
genome (such as protease genes) or only in some genomes (such as lipase genes), the costs could 
escalate to $10 000100 000 per open reading frame. Even if these costs do not seem unreasonable, 
the costs associated with the real commercial exploitation of a new enzyme (which includes all 
aspects of process development and optimization) are very much higher. 
 
Metagenome sequencing becomes more technically and financially feasible when biotopes harbouring 
relatively low genomic diversity, preferably without eukaryotic genomes, are considered. 
Hyperthermophilic biotopes would seem to be ideal targets, where species diversity is generally lower 
than eutrophic neutrophilic environments. In addition, hyperthermophilic biotopes are dominated by 
small archaeal genomes! We predict that for some biotopes expression library and PCR-dependent 
Figure 3 Accessing full-length genes using gene-specific PCR products 
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metagenomic gene-discovery methods may be rapidly outpaced by the speed, automation and 
efficiency of the sequencers of the future. 
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